Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years
Crossref DOI link: https://doi.org/10.1007/s00198-016-3886-y
Published Online: 2017-01-05
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Modi, A.
Sajjan, S.
Insinga, R.
Weaver, J.
Lewiecki, E. M.
Harris, S. T.
Funding for this research was provided by:
Merck
License valid from 2017-01-05